Financing ·
Jaguar Health reduces $10.8M secured promissory note by $5.05M via 547,898 shares to Streeterville Capital
JAGXJaguar Health, Inc.
On September 23, 2026, Jaguar Health, Inc. entered into exchange agreements with Streeterville Capital, LLC to reduce the outstanding balance of its $10,810,000 secured promissory note by $5,049,909.26. In consideration for this debt reduction, the Company issued 547,898 shares of common stock to Streeterville. Following this transaction, the total number of shares outstanding was approximately 1,281,867. Jaguar Health operates in the pharmaceutical industry, developing and commercializing treatments for gastrointestinal disorders.